meningococcal - meningitis
چکیده
چکیدهای برای این سند ثبت نشده است.
چکیدهای برای این سند ثبت نشده است.
Neurology 2012;79:1528–1529 In bacterial meningitis, lysis of bacteria during treatment triggers the release of cytokines that increase intrathecal inflammation. Studies with animals have shown that adjunctive treatment with glucocorticoids reduces both the inflammatory response
BACKGROUND: A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity. This vaccine is now being deployed across the African menin
BACKGROUND To facilitate the interpretation of meningococcal meningitis epidemiology in the "African meningitis belt", we aimed at obtaining serogroup-specific pooled estimates of incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis b
BACKGROUND A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity. This vaccine is now being deployed across the African mening
Background: Meningococcal meningitis is a disease of major public health importance especially for countries in the meningitis belt. The retrospective data analysis had provided helpful information to understand the current prevalence of meningococcal meningitis. The trends of me
BACKGROUND: To facilitate the interpretation of meningococcal meningitis epidemiology in the "African meningitis belt", we aimed at obtaining serogroup-specific pooled estimates of incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis